Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $5.7200 (-7.14%) ($5.7200 - $5.7200) on Wed. Apr. 7, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.68% (three month average) | RSI | 37 | Latest Price | $5.7200(-7.14%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -0.2% a day on average for past five trading days. | Weekly Trend | ANPC declines -7.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) IGOV(18%) GLD(15%) VXX(14%) SLV(11%) BNDX(9%) | Factors Impacting ANPC price | ANPC will decline at least -4.34% in a week (0% probabilities). ONLN(-16%) XLY(-12%) MCHI(-12%) FXI(-11%) VWO(-10%) | | | | | Relative Volatility | | | | Market Trend Strength | -4.34% (StdDev 8.68%) | Hourly BBV | -0.9 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-9.44(-265.03%) | Inflection Point | Yes | Resistance Level | $6.48 | 5 Day Moving Average | $5.91(-3.21%) | 10 Day Moving Average | $5.94(-3.7%) | 20 Day Moving Average | $6.48(-11.73%) | To recent high | -32.4% | To recent low | 3.6% | Market Cap | $49m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |